Author Shipkova, Maria

1 to 20 of 77 Items

2000 | Journal Article
Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit
Shipkova, M.; Schutz, E.; Armstrong, V. W.; Niedmann, P. D.; Oellerich, M. & Wieland, E. (2000)
Clinical Chemistry, 46(3) pp. 365-372.
Details PMID PMC WoS

2000 | Conference Paper
An ex vivo model to study the intestinal biotransformation of immunosuppressive drugs
Braun, F.; Christians, U.; Laabs, S.; Elias, K.; Shipkova, M.; Schutz, E. & Ringe, B. (2000)
Transplantation Proceedings, 32(7) 6th Congress of the Asian-Society-of-Transplantation, SUNTEC CITY, SINGAPORE.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0041-1345(00)01529-3
Details DOI PMID PMC WoS

2000 | Journal Article
Induction of cytokine release by the acyl glucuronide of mycophenolic acid: A link to side effects?
Wieland, E.; Shipkova, M.; Schellhaas, U.; Schütz, E.; Niedmann, P. D.; Armstrong, V. W. & Oellerich, M. (2000)
Clinical Biochemistry, 33(2) pp. 107-113. DOI: https://doi.org/10.1016/S0009-9120(99)00101-0
Details DOI PMID PMC WoS

2000 | Conference Paper
New strategies in GVHD prophylaxis
Kiehl, M. G.; Shipkova, M.; Basara, N.; Blau, W. I. & Fauser, A. A. (2000)
Bone Marrow Transplantation, 25 pp. S16-S19. 2nd International Symposium on Transplantation and Gene Therapy, IDAR OBERSTEIN, GERMANY.
Basingstoke: Nature Publishing Group. DOI: https://doi.org/10.1038/sj.bmt.1702346
Details DOI PMID PMC WoS

2000 | Conference Paper
An ex vivo model to study the intestinal biotransformation of immunosuppressives
Braun, F.; Christians, U.; Laabs, S.; Elias, K.; Shipkova, M.; Schutz, E. & Ringe, B. (2000)
Transplantation Proceedings, 32(7) 6th Congress of the Asian-Society-of-Transplantation, SUNTEC CITY, SINGAPORE.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0041-1345(00)01780-2
Details DOI PMID PMC WoS

2000 | Journal Article
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring
Oellerich, M.; Shipkova, M.; Schutz, E.; Wieland, E.; Weber, L. T.; Tonshoff, B. & Armstrong, V. W. (2000)
Therapeutic Drug Monitoring, 22(1) pp. 20-26. DOI: https://doi.org/10.1097/00007691-200002000-00004
Details DOI PMID PMC WoS

2000 | Journal Article
Mycophenolate mofetil decreases endothelial prostaglandin E-2 in response to allogeneic T cells or cytokines
Blaheta, R. A.; Nelson, K.; Oppermann, E.; Leckel, K.; Harder, S.; Cinatl, J. & Weber, S. et al. (2000)
Transplantation Journal, 69(9) pp. 1977-1981. DOI: https://doi.org/10.1097/00007890-200005150-00044
Details DOI PMID PMC WoS

2000 | Journal Article | Letter Note
Evaluation of an immunoassay for mycophenolic acid
Schutz, E.; Shipkova, M.; Wieland, E.; Niedmann, P. D.; Armstrong, V. W. & Oellerich, M. (2000)
Therapeutic Drug Monitoring, 22(1) pp. 141-142. DOI: https://doi.org/10.1097/00007691-200002000-00030
Details DOI PMID PMC WoS

2000 | Conference Paper
The monoethylglycinexylidide (MEGX) test as a marker of hepatic dysfunction in septic patients with pneumonia
Igonin, A. A.; Armstrong, V. W.; Shipkova, M.; Kukes, V. G. & Oellerich, M. (2000)
Clinical Chemistry and Laboratory Medicine (CCLM), 38(11) pp. 1125-1128. European Meeting on Biomarkers of Organ Damage and Dysfunction, CAMBRIDGE, ENGLAND.
Berlin: Walter De Gruyter & Co. DOI: https://doi.org/10.1515/CCLM.2000.169
Details DOI PMID PMC WoS

2000 | Journal Article
Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite
Kiehl, M. G.; Shipkova, M.; Basara, N.; Blau, I. W.; Schutz, E.; Armstrong, V. W. & Oellerich, M. et al. (2000)
Clinical Biochemistry, 33(3) pp. 203-208. DOI: https://doi.org/10.1016/S0009-9120(00)00053-9
Details DOI PMID PMC WoS

2001 | Journal Article | Letter Note
Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil
Shipkova, M.; Armstrong, V. W.; Kiehl, M. G.; Niedmann, P. D.; Schutz, E.; Oellerich, M. & Wieland, E. (2001)
Clinical Chemistry, 47(8) pp. 1485-1488.
Details PMID PMC WoS

2001 | Journal Article | Letter Note
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of monoethylglycinexylidide
Streit, F.; Niedmann, P. D.; Shipkova, M.; Armstrong, V. W. & Oellerich, M. (2001)
Clinical Chemistry, 47(10) pp. 1853-1856.
Details PMID PMC WoS

2001 | Conference Abstract
Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients.
Kiehl, M. G.; Schaefer-Eckart, K.; Kienast, J.; Jenke, A.; Wandt, H.; Blau, I. W. & Shipkova, M. et al. (2001)
Blood, 98(11) pp. 664A-665A.
Washington: Amer Soc Hematology.
Details WoS

2001 | Conference Paper
The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes
Shipkova, M.; Wieland, E.; Schutz, E.; Wiese, C. H.; Niedmann, P. D.; Oellerich, M. & Armstrong, V. W. (2001)
Transplantation Proceedings, 33(1-2) pp. 1080-1081. 18th World Congress of the Transplantation-Society, ROME, ITALY.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0041-1345(00)02424-6
Details DOI PMID PMC WoS

2001 | Conference Paper
Monitoring of mycophenolic acid in pediatric renal transplant recipients
Armstrong, V. W.; Shipkova, M.; Schutz, E.; Weber, L. T.; Tonshoff, B. & Oellerich, M. (2001)
Transplantation Proceedings, 33(1-2) pp. 1040-1043. 18th World Congress of the Transplantation-Society, ROME, ITALY.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0041-1345(00)02322-8
Details DOI PMID PMC WoS

2001 | Conference Paper
Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liver perfusion model
Wieland, E.; Shipkova, M.; Schütz, E.; Braun, F.; Niedmann, P.-D.; Armstrong, V. W. & Ringe, B. et al. (2001)
Clinical Biochemistry, 34(1) pp. 53-57. Analytical Conference 2000, MUNICH, GERMANY.
Oxford: Pergamon-elsevier Science Ltd. DOI: https://doi.org/10.1016/S0009-9120(00)00203-4
Details DOI PMID PMC WoS

2001 | Journal Article
Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: Preliminary report
Shipkova, M.; Armstrong, V. W.; Kuypers, D.; Perner, F.; Fabrizi, V.; Holzer, H. & Wieland, E. et al. (2001)
Therapeutic Drug Monitoring, 23(6) pp. 717-721. DOI: https://doi.org/10.1097/00007691-200112000-00020
Details DOI PMID PMC WoS

2001 | Journal Article
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes
Shipkova, M.; Strassburg, C. P.; Braun, F.; Streit, F.; Grone, H. J.; Armstrong, V. W. & Tukey, R. H. et al. (2001)
British Journal of Pharmacology, 132(5) pp. 1027-1034. DOI: https://doi.org/10.1038/sj.bjp.0703898
Details DOI PMID PMC WoS

2002 | Conference Abstract
Results of a 12 month multicenter trial investigating the kinetics of MPA and MPA-metabolites and the efficacy and side-effect profile of mycophenolate mofetil in renal transplant patients in view of MPA and MPA-metabolites.
Kuypers, D.; Vanrenterghem, Y.; Squifflet, J. P.; Mourad, M.; Abramowicz, D.; Oellerich, H. & Armstrong, V. W. et al. (2002)
Journal of the American Society of Nephrology, 13 pp. 367A-368A.
Philadelphia: Lippincott Williams & Wilkins.
Details WoS

2002 | Journal Article
Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy
Weber, L. T.; Shipkova, M.; Armstrong, V. W.; Wagner, N.; Schutz, E.; Mehls, O. & Zimmerhackl, L. B. et al. (2002)
Clinical Chemistry, 48(3) pp. 517-525.
Details PMID PMC WoS

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100